Cargando…

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung

BACKGROUND: A primary pulmonary invasive mucinous adenocarcinoma (IMA) is a rare subtype of invasive adenocarcinoma of the lung. The prognosis of advanced IMA depending on chemotherapy regimen has not been fully investigated. Here, we compared the clinical outcomes of patients with advanced IMA trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Yoon Jung, Hyun, Dong-gon, Choi, Chang-Min, Lee, Dae Ho, Kim, Sang-We, Yoon, Shinkyo, Kim, Woo Sung, Ji, Wonjun, Lee, Jae Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235206/ https://www.ncbi.nlm.nih.gov/pubmed/34174841 http://dx.doi.org/10.1186/s12885-021-08472-6

Ejemplares similares

Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment
por: Jang, Yoon Jung, et al.
Publicado: (2023)

Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis
por: Hyun, Dong-gon, et al.
Publicado: (2020)

Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
por: Choi, Myeong Geun, et al.
Publicado: (2021)

Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment
por: Choi, Myeong Geun, et al.
Publicado: (2022)

Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma
por: Kim, Jwa Hoon, et al.
Publicado: (2021)

Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations
por: Kim, Ho Cheol, et al.
Publicado: (2019)

Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis
por: Yoon, Byung Woo, et al.
Publicado: (2019)

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Cho, Su Han, et al.
Publicado: (2021)

Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy
por: Lee, Jae Woo, et al.
Publicado: (2018)

Endoscopic Ultrasound-Guided Sampling of a Metastatic Mucinous Adenocarcinoma Mimicking a Gastric Subepithelial Tumor
por: Seo, Dae Chul, et al.
Publicado: (2014)

Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
por: Woo, Wongi, et al.
Publicado: (2022)

Recurrence dynamics after curative surgery in patients with invasive mucinous adenocarcinoma of the lung
por: Yoon, Hyun Jung, et al.
Publicado: (2022)

Genomic characteristics of invasive mucinous adenocarcinoma of the lung with multiple pulmonary sites of involvement
por: Kim, Moonsik, et al.
Publicado: (2021)

Prognostic Comparison Between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer
por: Park, Jong Seob, et al.
Publicado: (2015)

Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas
por: Jun, Dae Young, et al.
Publicado: (2011)

Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
por: Won, Sang Eun, et al.
Publicado: (2020)

Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma
por: Cui, Dongyu, et al.
Publicado: (2023)

Prognosis and Sensitivity of Adjuvant Chemotherapy in Mucinous Colorectal Adenocarcinoma without Distant Metastasis
por: Bong, Jun-Woo, et al.
Publicado: (2022)

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
por: Jeong, Hyehyun, et al.
Publicado: (2022)

Invasive mucinous adenocarcinoma of the lung
por: Xu, Lu, et al.
Publicado: (2019)

Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma
por: Kim, Dae Hyeon, et al.
Publicado: (2021)

Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor
por: Kwon, Byoung Soo, et al.
Publicado: (2020)

An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma
por: Kim, Yeseul, et al.
Publicado: (2023)

Mucinous adenocarcinoma of the buttock associated with hidradenitis: A case report
por: Kim, Sung Jin, et al.
Publicado: (2020)

Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
por: Kim, Hong Jun, et al.
Publicado: (2020)

Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria
por: Roh, Yun Hwa, et al.
Publicado: (2023)

Prognosis for Pneumonic-Type Invasive Mucinous Adenocarcinoma in a Single Lobe on CT: Is It Reasonable to Designate It as Clinical T3?
por: Kim, Wooil, et al.
Publicado: (2022)

Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer
por: Ji, Wonjun, et al.
Publicado: (2013)

Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR
por: Choi, Yoon Ji, et al.
Publicado: (2015)

Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign
por: Cha, Min Jae, et al.
Publicado: (2019)

Invasive mucinous adenocarcinoma of the lung: Serial CT findings, clinical features, and treatment and survival outcomes
por: Beck, Kyongmin Sarah, et al.
Publicado: (2020)

Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
por: Baek, Sun Kyung, et al.
Publicado: (2019)

Primary mucinous adenocarcinoma of the vulva, intestinal type
por: Lee, In Ho, et al.
Publicado: (2017)

A case of bilateral invasive mucinous adenocarcinoma of the lung with severe productive cough and dyspnea successfully treated with palliative lung lobectomy
por: Horiguchi, Takanori, et al.
Publicado: (2021)

Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma
por: Gow, Chien-Hung, et al.
Publicado: (2021)

Gene signature driving invasive mucinous adenocarcinoma of the lung
por: Guo, Minzhe, et al.
Publicado: (2017)

Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax
por: Aoki, Ayako, et al.
Publicado: (2020)

Invasive Mucinous Adenocarcinoma of the Lung Presenting With Multiple Cavities
por: Nakamura, Shunsuke, et al.
Publicado: (2021)

Pulmonary invasive mucinous adenocarcinoma mimicking pulmonary actinomycosis
por: Zhu, Dongyi, et al.
Publicado: (2022)

HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells
por: Park, Kang-Seo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pa9ccula4k8mq08p93b8kivhr6